Background Idiopathic inflammatory myopathy (IIM) is a multi-system autoimmune condition
characterised by muscle inflammation (myositis), interstitial lung disease (ILD), and skin …

The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM),
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …

Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis
(PM). Methods Expert surveys, logistic regression, and conjoint analysis were used to …

Juvenile idiopathic arthritis (JIA), as a chronic condition, is associated with significant
disease-and treatment-related morbidity, thus impacting children's quality of life. In order to …

The adult and juvenile myositis syndromes, commonly referred to collectively as idiopathic
inflammatory myopathies (IIMs), are systemic autoimmune diseases with the hallmarks of …

The childhood-onset or juvenile idiopathic inflammatory myopathies (JIIMs) are a
heterogenous group of rare and serious autoimmune diseases of children and young …

Juvenile onset idiopathic inflammatory myopathy (IIM) has many similarities and distinct
differences from adult-onset disease. This review will focus on recent developments in …

Objectives To develop data-driven criteria for clinically inactive disease on and off therapy
for juvenile dermatomyositis (JDM). Methods The Paediatric Rheumatology International …

Juvenile dermatomyositis (JDM) is a rare, potentially life-threatening systemic autoimmune
disease primarily affecting muscle and skin. Recent advances in the recognition …

Objective This open‐label, 24‐week study was conducted to evaluate the safety and efficacy
of abatacept in patients with refractory juvenile dermatomyositis (DM). Methods Ten …